Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jay B Shah

Showing results (21-30 of 71) with videos related to

Pageof 8
Sort By:
Bladder Cancer (Amsterdam, Netherlands)|August 9, 2016
Assessing Symptom Burden in Bladder Cancer: An Overview of Bladder Cancer Specific Health-Related Quality of Life InstrumentsBernard J Danna, Michael J Metcalfe, Erika L Wood, et al.
Urology|May 11, 2016
The Future of Enhanced Recovery for Radical Cystectomy: Current Evidence, Barriers to Adoption, and the Next StepsBernard J Danna, Erika L Wood, Janet E Baack Kukreja, et al.
Urology|February 8, 2006
Does year of radical prostatectomy independently predict outcome in prostate cancer?Robert E Mitchell, Jay B Shah, Carl A Olsson, et al.
The Journal of Urology|November 13, 2007
Prostate biopsy patterns in the CaPSURE database: evolution with time and impact on outcome after prostatectomyJay B Shah, James M McKiernan, Eric P Elkin, et al.
The Journal of Urology|April 8, 2006
Preoperative serum prostate specific antigen remains a significant prognostic variable in predicting biochemical failure after radical prostatectomyRobert E Mitchell, Manisha Desai, Jay B Shah, et al.
BJU International|August 30, 2012
Demographic analysis of randomized controlled trials in bladder cancerBassel G Bachir, Shahrokh F Shariat, Alexandre Zlotta, et al.
Bladder Cancer (Amsterdam, Netherlands)|December 19, 2018
Is Exam under Anesthesia Still Necessary for the Staging of Bladder Cancer in the Era of Modern Imaging?Alexander T Rozanski, Cooper R Benson, Jacob A McCoy, et al.
Urology|August 21, 2007
Changes in prognostic significance and predictive accuracy of Gleason grading system throughout PSA era: impact of grade migration in prostate cancerRobert E Mitchell, Jay B Shah, Manisha Desai, et al.
European Urology|February 29, 2016
Papillary Recurrence of Bladder Cancer at First Evaluation after Induction Bacillus Calmette-Guérin Therapy: Implication for Clinical Trial DesignChinedu O Mmeje, Charles C Guo, Jay B Shah, et al.
Cancer|June 24, 2010
A multiplexed, particle-based flow cytometric assay identified plasma matrix metalloproteinase-7 to be associated with cancer-related death among patients with bladder cancerRobert S Svatek, Jay B Shah, Jinliang Xing, et al.
Pageof 8

Showing results (21-30 of 71) with videos related to

Sort By:
Pageof 8
Bladder Cancer (Amsterdam, Netherlands)|August 9, 2016
Assessing Symptom Burden in Bladder Cancer: An Overview of Bladder Cancer Specific Health-Related Quality of Life InstrumentsBernard J Danna, Michael J Metcalfe, Erika L Wood, et al.
Urology|May 11, 2016
The Future of Enhanced Recovery for Radical Cystectomy: Current Evidence, Barriers to Adoption, and the Next StepsBernard J Danna, Erika L Wood, Janet E Baack Kukreja, et al.
Urology|February 8, 2006
Does year of radical prostatectomy independently predict outcome in prostate cancer?Robert E Mitchell, Jay B Shah, Carl A Olsson, et al.
The Journal of Urology|November 13, 2007
Prostate biopsy patterns in the CaPSURE database: evolution with time and impact on outcome after prostatectomyJay B Shah, James M McKiernan, Eric P Elkin, et al.
The Journal of Urology|April 8, 2006
Preoperative serum prostate specific antigen remains a significant prognostic variable in predicting biochemical failure after radical prostatectomyRobert E Mitchell, Manisha Desai, Jay B Shah, et al.
BJU International|August 30, 2012
Demographic analysis of randomized controlled trials in bladder cancerBassel G Bachir, Shahrokh F Shariat, Alexandre Zlotta, et al.
Bladder Cancer (Amsterdam, Netherlands)|December 19, 2018
Is Exam under Anesthesia Still Necessary for the Staging of Bladder Cancer in the Era of Modern Imaging?Alexander T Rozanski, Cooper R Benson, Jacob A McCoy, et al.
Urology|August 21, 2007
Changes in prognostic significance and predictive accuracy of Gleason grading system throughout PSA era: impact of grade migration in prostate cancerRobert E Mitchell, Jay B Shah, Manisha Desai, et al.
European Urology|February 29, 2016
Papillary Recurrence of Bladder Cancer at First Evaluation after Induction Bacillus Calmette-Guérin Therapy: Implication for Clinical Trial DesignChinedu O Mmeje, Charles C Guo, Jay B Shah, et al.
Cancer|June 24, 2010
A multiplexed, particle-based flow cytometric assay identified plasma matrix metalloproteinase-7 to be associated with cancer-related death among patients with bladder cancerRobert S Svatek, Jay B Shah, Jinliang Xing, et al.
Pageof 8